Skip to main content

Table 2 Duration of response

From: Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

Targeted Therapy

N = 33

Stable disease as best response

Median duration of response (months)

Sirolimus alone

3

1

4,75

Sirolimus Cy

13

7 (3 maintained complete remission)

5,4

Sirolimus Cy Adriamycine

1

1

6,2

Sirolimus Cy Vinorelbine

3

0

 

Sirolimus Cy Zolendronate

1

1

9

Sirolimus Irinotecan

2

0

 

Sorafenib

4

3

3,1

Sunitinib

5

2 (1 PR)

3,4

Pazopanib

1

0

 

Total

33

15

4,8

  1. Cy cyclophosphamide